Shares of vaccine makers Pfizer, GSK and Moderna dropped Wednesday as advisers to the Centers for Disease Control and Prevention shifted their recommendations for who should be vaccinated against respiratory syncytial virus.
Source link
Supreme Court to hear a new challenge to the scope of federal agency power
The Federal Communications Commission (FCC) seal hangs inside a meeting room at the headquarters ahead of a open commission meeting...